VIVUS, Inc. (NASDAQ:VVUS)
CAPS Rating:
A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.
RSS Headlines
Fool UK
Recs
$1 billion dollar well with no buckets in it...until VVUS and OREX.